Vanessa Hamann is a Senior Scientist in RNA Delivery at Bayer Pharmaceuticals, specializing in cell and gene therapy for inherited liver diseases. They focus on innovative technologies aimed at correcting genetic mutations and developing therapeutic approaches for conditions with limited treatment options. Previously, Vanessa was a PhD student at Medizinische Hochschule Hannover from 2021 to 2025, building on their education which includes a Master of Science and a Bachelor of Science from the same institution and Universität Osnabrück, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices